Skip to content

A randomized controlled double-blinded clinical trial

Evaluation of the effectiveness of autologous fat transfer on the quality of burn-induced scars

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221012056155N1
Enrollment
20
Registered
2023-01-29
Start date
2022-12-31
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Scars. Condition 2: Burn of head, face, and neck sequela. Condition 3: Burn of trunk sequela. Condition 4: Burn of limbs sequela. Condition 5: Burn of Lower Limb sequela. Condition 6: hypertrophic scar. Scar conditions and fibrosis of skin Burn of unspecified degree of head, face, and neck, unspecified site, sequela Burn of unspecified degree of trunk, unspecified site, sequela Burn of unspecified degree of shoulder and upper limb, except wrist and hand, unspecified site, sequel

Interventions

Intervention 1: First, the subcision and release of adhesions in the subdermal area of the specified location for fat injection are performed with a standard blunt cannula with a diameter of 1.5 mm. A

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Burn-induced scars anywhere on the trunk or limbs or face or neck The minimal interval between burn injury and intervention(fat grafting) should not be less than one year(Mature Scars)

Exclusion criteria

Exclusion criteria: Any significant systemic disease or morbidity ( e.g. Cardiac disease, Endocrine disease, Respiratory Disease etc) Any patient with an American Society of Anesthesiologist Physical Status Classification System score>II indicating increased anesthesia risk Low Body Mass Index (BMI) (Less than 19kg/m²) Known Systemic Immune Disorder (Acquired or inherited immune deficiency)

Design outcomes

Primary

MeasureTime frame
Overall Scar Score (Observer). Timepoint: Before intervention and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Overall Scar Score (Patient). Timepoint: Before intervention and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.

Secondary

MeasureTime frame
Scar Vascularity. Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Pigmentation (Observer Score). Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Thickness (Observer Score). Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Relief (Observer Score). Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Pliability (Observer Score). Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Surface Area. Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Pain. Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Itching. Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Color Difference (Patient Score). Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Stiffness (Patient Score). Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Scar Thickness (Patient Score). Timepoint: Before interventions and three months after intervention. Method of measurement: Patient and Observer Scar Asse

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed-ehsan Mousavi-lajimi

Iran University of Medical Sciences

s.ehsan.mousavi@gmail.com+98 21 8835 1450

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026